
OIG Report on Lab Testing Should Prompt Compliance Review
Genetic testing now accounts for 43 percent of all Medicare Part B laboratory spending

Genetic testing now accounts for 43 percent of all Medicare Part B laboratory spending

Cuts to reimbursement rates under PAMA have been pushed back again by Congress, this time to January 2027

However, attorney Danielle Sloane urges labs to be proactive about potential PAMA reporting requirements on Jan. 31 if the bill doesn’t pass quickly

Better clinical laboratory test data reporting would allow ‘Medicare rates to be more appropriately set,’ says Susan Van Meter

However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities